In this research study, the investigators want to learn more about the use of donor-derived viral specific T-cells (VSTs) to treat viral infections that occur …

Allogeneic Stem Cell TransplantViral InfectionViral Reactivation

~Estimated

~$10 – $5,625

Children's Hospital Medical Center, CincinnatiNCT02048332

Phase 2

Third Party Viral Specific T-cells (VSTs) for Treatment of Viral Infections in Immunocompromised Patients

The purpose of this study is to demonstrate that viral specific T-cells (a type of white blood cell) can be generated from an unrelated donor and given safely …

Viral InfectionViral ReactivationInfection in an Immunocompromised Host

~Estimated

~$10 – $5,625

Children's Hospital Medical Center, CincinnatiNCT02532452